Literature DB >> 3897378

Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults.

R A Insel, A Kittelberger, P Anderson.   

Abstract

Serum antibody to the capsular polysaccharide of Haemophilus influenzae b of human adults was analyzed by isoelectric focusing. Restricted antibody spectrotype patterns were commonly observed with as few as one spectrotype in some subjects after immunization with the isolated capsular polysaccharide. Some patterns were as restricted as human hybridoma antibody. There was no correlation of antibody titer and heterogeneity of patterns. The dominant spectrotype persisted unchanged for over 2 yr after immunization, and the pattern detected in preimmunization serum samples persisted unchanged after immunization. Indistinguishable patterns were commonly observed in genetically unrelated adults. Adults immunized with conjugate vaccines, which were composed of oligosaccharides prepared from the capsular polysaccharide that were covalently linked to protein carriers, also produced restricted serum antibody spectrotype patterns. Immunization with the cross-reactive polysaccharide of E. coli K100 induced a spectrotype pattern that was restricted but different from that induced by the H. influenzae b capsular polysaccharide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  Factors that influence formation of B cell repertoire.

Authors:  A J Feeney
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F.

Authors:  Jianhui Zhou; Kathleen R Lottenbach; Stephen J Barenkamp; Alexander H Lucas; Donald C Reason
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.

Authors:  I Quinti; A Velardi; S Le Moli; E Guerra; R D'Amelio; P Mastrantonio; M F Martelli; F Aiuti
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

4.  Regulatory T cells in the antibody response to Haemophilus influenzae type b polysaccharide.

Authors:  M A Breukels; G T Rijkers; M M Voorhorst-Ogink; B J Zegers
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 5.  Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.

Authors:  E E Adderson
Journal:  Springer Semin Immunopathol       Date:  2001-12

6.  A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass.

Authors:  A H Lucas; D M Granoff
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

7.  Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency.

Authors:  K H Kim; M K Park; C C Peeters; J T Poolman; M H Shearer; R C Kennedy; M H Nahm
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants.

Authors:  G H Chung; K H Kim; R S Daum; R A Insel; G R Siber; S Sood; R K Gupta; C Marchant; M H Nahm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates.

Authors:  G J Zigterman; K Schotanus; E B Ernste; G J Van Dam; M Jansze; H Snippe; J M Willers
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

10.  Antibody response to the Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in healthy and infection-prone individuals with IgG3 subclass deficiency.

Authors:  M Hahn-Zoric; M Ulanova; V Friman; J Björkander; V A Oxelius; A Lucas; L A Hanson
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.